Aprea Therapeutics Statistics
Total Valuation
APRE has a market cap or net worth of $9.03 million. The enterprise value is -$37.82 million.
Important Dates
The last earnings date was Wednesday, May 13, 2026, before market open.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
APRE has 12.38 million shares outstanding. The number of shares has increased by 46.20% in one year.
| Current Share Class | 12.38M |
| Shares Outstanding | 12.38M |
| Shares Change (YoY) | +46.20% |
| Shares Change (QoQ) | +91.02% |
| Owned by Insiders (%) | 11.31% |
| Owned by Institutions (%) | 9.95% |
| Float | 7.42M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 70.16 |
| Forward PS | 18.62 |
| PB Ratio | 0.20 |
| P/TBV Ratio | 0.21 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.92
| Current Ratio | 8.92 |
| Quick Ratio | 8.77 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -40.40% and return on invested capital (ROIC) is -26.57%.
| Return on Equity (ROE) | -40.40% |
| Return on Assets (ROA) | -23.18% |
| Return on Invested Capital (ROIC) | -26.57% |
| Return on Capital Employed (ROCE) | -29.73% |
| Weighted Average Cost of Capital (WACC) | 12.81% |
| Revenue Per Employee | $15,412 |
| Profits Per Employee | -$1.49M |
| Employee Count | 8 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -60.36% in the last 52 weeks. The beta is 1.56, so APRE's price volatility has been higher than the market average.
| Beta (5Y) | 1.56 |
| 52-Week Price Change | -60.36% |
| 50-Day Moving Average | 0.85 |
| 200-Day Moving Average | 1.02 |
| Relative Strength Index (RSI) | 41.39 |
| Average Volume (20 Days) | 133,032 |
Short Selling Information
The latest short interest is 119,012, so 0.96% of the outstanding shares have been sold short.
| Short Interest | 119,012 |
| Short Previous Month | 147,564 |
| Short % of Shares Out | 0.96% |
| Short % of Float | 1.60% |
| Short Ratio (days to cover) | 0.62 |
Income Statement
In the last 12 months, APRE had revenue of $123,296 and -$11.95 million in losses. Loss per share was -$1.37.
| Revenue | 123,296 |
| Gross Profit | -6.05M |
| Operating Income | -12.58M |
| Pretax Income | -11.95M |
| Net Income | -11.95M |
| EBITDA | -12.56M |
| EBIT | -12.58M |
| Loss Per Share | -$1.37 |
Full Income StatementBalance Sheet
The company has $46.47 million in cash and n/a in debt, with a net cash position of $46.47 million or $3.75 per share.
| Cash & Cash Equivalents | 46.47M |
| Total Debt | n/a |
| Net Cash | 46.47M |
| Net Cash Per Share | $3.75 |
| Equity (Book Value) | 42.32M |
| Book Value Per Share | 3.47 |
| Working Capital | 41.95M |
Full Balance SheetCash Flow
| Operating Cash Flow | -12.02M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 21,714 |
| Net Borrowing | n/a |
| Free Cash Flow | -12.02M |
| FCF Per Share | -$0.97 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -10,202.01% |
| Pretax Margin | -9,696.04% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
APRE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -46.20% |
| Shareholder Yield | -46.20% |
| Earnings Yield | -138.20% |
| FCF Yield | -138.95% |
Analyst Forecast
The average price target for APRE is $4.30, which is 489.61% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.30 |
| Price Target Difference | 489.61% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 91.63% |
| EPS Growth Forecast (3Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 13, 2023. It was a reverse split with a ratio of 1:20.
| Last Split Date | Feb 13, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
APRE has an Altman Z-Score of -8.8 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -8.8 |
| Piotroski F-Score | 1 |
